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ReviewThe Need to Feed:
Homeostatic and Hedonic
Control of Eating
mechanisms that underlie regulation of feeding and
make it such a rewarding experience (Figure 1).
Homeostatic Mechanisms for Regulating Feeding
To ensure adequate nutrition, it is necessary for the
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Beth Israel Deaconess Medical Center One could argue that the homeostatic drive for feeding
Boston, Massachusetts 02215 is not intrinsically related to the rewarding aspects of
the behavior. However, avoiding or terminating the dis-
comfort associated with hunger provides a strong drive
for feeding. In addition, the feeling of contentment that
Feeding provides substrate for energy metabolism, accompanies a full stomach may itself be rewarding,
which is vital to the survival of every living animal and in the absence of a homeostatic drive to eat, food
and therefore is subject to intense regulation by brain consumption loses much of its allure (i.e., loss of appe-
homeostatic and hedonic systems. Over the last de- tite). Thus, to understand the rewarding nature of food,
cade, our understanding of the circuits and molecules it is necessary first to understand the brain mechanisms
involved in this process has changed dramatically, in that support the homeostatic drive for feeding.
large part due to the availability of animal models with For many years, descriptions of the brain mechanisms
genetic lesions. In this review, we examine the role for regulating the homeostatic drive to eat were fixated
played in homeostatic regulation of feeding by sys- on a model of two opposing cell groups, the lateral
temic mediators such as leptin and ghrelin, which act hypothalamus driving feeding and the ventromedial nu-
on brain systems utilizing neuropeptide Y, agouti- cleus inhibiting it to cause satiety. Although this model
related peptide, melanocortins, orexins, and melanin contains some useful elements, it was largely exploded
concentrating hormone, among other mediators. We by advances in the late 1990s that were based upon the
also examine the mechanisms for taste and reward discovery that a systemic hormone, leptin, produced by
systems that provide food with its intrinsically rein- white adipose tissue during times of plenty, is a neces-
forcing properties and explore the links between the sary (but not sufficient) stimulus for satiety. Several re-
homeostatic and hedonic systems that ensure intake cent reviews have detailed components of the circuitry
of adequate nutrition. underlying body weight regulation (Ahima et al., 2000;
Barsh and Schwartz, 2002; Elmquist et al., 1998c, 1999;
Friedman and Halaas, 1998; Schwartz et al., 2000; Spie-
gelman and Flier, 2001; Woods et al., 1998), and thisConsuming sufficient food to maintain adequate energy
information need not be repeated here in detail. Instead,stores is the sine qua non for survival for all species in
we will outline this circuitry briefly and focus on recentthe animal kingdom. For mammals, which must maintain
developments that have clarified and enhanced (anda stable body temperature in even the most hostile cli-
in some cases challenged) our understanding of thismates to survive, this problem is even more acute. Main-
process.taining a high metabolic rate requires constant availabil-
Leptin: A Peripheral Signal Regulating Bodyity of large amounts of energy stores. For small
Weight Homeostasismammals that do not retain heat well, life consists mainly
The discovery of leptin in 1994 acted as a catalyst thatof obtaining and consuming food.
moved the field of body weight homeostasis into theTo insure that this activity takes a high priority in brain
molecular era. Using the arduous method of positionalfunction, mammalian brains have evolved several potent
cloning, Zhang and colleagues identified the mutationand interrelated neuronal systems that drive feeding
resulting in obesity in the extensively studied ob/obbehavior. Certainly one of the most potent drives for
mouse (Zhang et al., 1994). They found that the ob genefeeding is its rewarding nature. Few experiences in life
encoded a hormone that was made and secreted byare more satisfying than consuming a well-prepared
white adipose tissue. They dubbed the OB protein “lep-meal, and the complex flavors and textures of food are
tin,” from the Greek root leptos or thin. A number ofbest appreciated when one starts in a hungry (rather
subsequent studies demonstrated that leptin levels inthan satiated) state. Because of these rewarding proper-
the blood increase when animals are fed and fall whenties, humans and animals will work for food (the quintes-
animals are deprived of food (Ahima et al., 2000; Freder-sential definition of a reward, i.e., the willingness to en-
ich et al., 1995a, 1995b; Maffei et al., 1995). Moreover,gage in otherwise unrelated behaviors that quickly
it quickly became clear that leptin replacement in ob/extinguish in the absence of the reward). Thus, to under-
ob mice corrected their characteristic behavioral, neuro-stand the rewarding nature of food, it is necessary to
endocrine, and autonomic abnormalities (Campfield etconsider the various homeostatic and hedonic sensory
al., 1995; Halaas et al., 1995; Pelleymounter et al., 1995).
Approximately 1 year later, it was demonstrated that the
db/db mouse had a mutation in the long form of the4 Correspondence: csaper@caregroup.harvard.edu
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Figure 1. A Summary Diagram Showing Ma-
jor Pathways that Distribute Circadian, Ho-
meostatic, and Sensory Afferent Feeding In-
puts to the Brain
Note the convergence of these drives at the
level of the hypothalamus. AgRP, agouti-
related protein; AIC, agranular insular cortex;
ARC, arcuate hypothalamic nucleus; CART,
cocaine and amphetamine regulated tran-
script; CGRP, calcitonin-gene related pep-
tide; DMH, dorsomedial hypothalamic nu-
cleus; GIC, granular insular cortex; ILC,
infralimbic cortex; LHA, lateral hypothalamic
area; NAc, nucleus accumbens; NPY, neuro-
peptide Y; NTS, nucleus of the solitary tract;
PB, parabrachial nucleus; POMC, pro-opiomelanocortin; PVH parventricular hypothalamic nucleus; SCn, suprachiasmatic nucleus; SPZ,
subparaventricular zone; VMH, ventromedial hypothalamic nucleus; VPpc, ventroposterior parvicellular thalamic nucleus.
leptin receptor (Chen et al., 1996; Chua et al., 1996; Lee (-MSH), as well as cocaine and amphetamine-related
transcript (CART). The POMC/CART neurons show bothet al., 1996; Tartaglia et al., 1995). Although the high
leptin levels in obese humans indicate that the presence Fos and SOCS-3 expression after leptin, suggesting that
they have been activated. This is supported by the ob-of excess leptin is not a strong inhibitor of feeding, the
ravenous appetite in humans or animals that lack the servation that leptin directly depolarizes POMC neurons
in hypothalamic slices (Cowley et al., 2001). POMC neu-leptin receptor or ligand indicate that its absence is a
strong stimulus to induce feeding (Barsh and Schwartz, rons innervate the paraventricular nucleus, as well as
the melanin concentrating hormone (MCH) and orexin/2002).
How does circulating leptin act on CNS regulation of hypocretin (ORX/HO) cells in the LHA, and sympathetic
preganglionic neurons in the spinal cord (Elias et al.,feeding? The leptin receptor is a type 1 cytokine recep-
tor exerting its effects by activating the janus-kinase/ 1998a, 1998b, 1999; Elmquist et al., 1998c) (Figure 2).
The NPY/AgRP neurons express SOCS-3 but not FosSTAT-3 pathway (Tartaglia, 1997; Tartaglia et al., 1995).
The long form of the leptin receptor is present in several after leptin administration, suggesting that they are in-
hibited (Elias et al., 1999; Cowley et al., 2001; Spanswickbrain sites, with the most dense expression being found
in the ventral basal hypothalamus (Barsh and Schwartz, et al., 1997; Spanswick et al., 2000). They innervate many
of the same targets as the POMC/CART cells (although2002; Cheung et al., 1997; Elmquist et al., 1998b; Fei et
al., 1997; Hakansson et al., 1996; Mercer et al., 1996; probably not the spinal cord). In the hypothalamus,
-MSH contained in the POMC terminals is an agonistSchwartz et al., 1996), especially the arcuate, ventrome-
dial, dorsomedial, and ventral premammalliary nuclei in at melanocortin-4 receptors, whereas AgRP is a peptide
antagonist at the same receptors. Thus, the NPY/AgRPthe hypothalamus. The neurons that bear high levels of
leptin receptors cluster around the median eminence, neurons are thought to constitute a potent feeding sys-
tem that is actively opposed by the POMC/CART satietythe floor of the third ventricle which lacks a blood-brain
barrier. Studies using circulating radiolabeled leptin indi- system, and leptin apparently can push the balance
toward the latter.cate that it binds to these regions in rat brain. Although
circulating leptin binds primarily to these hypothalamic Ghrelin: A Peripheral Signal Regulating
Feeding Drivecell groups, leptin receptors are expressed (albeit at
lower levels) in several extrahypothalamic sites, includ- Recently, ghrelin, another nutritionally regulated hor-
mone that may act in concert with leptin, has receiveding the brainstem. The physiological significance of lep-
tin receptor expression in these sites is not as estab- considerable attention (Bagnasco et al., 2002; Horvath
et al., 2001; Kojima et al., 1999; Nakazato et al., 2001;lished, but it is likely that they contribute to the diverse
effects of leptin and leptin deficiency (Elmquist et al., Shintani et al., 2001; Tschop et al., 2000). The existence
of ghrelin had been foreshadowed in the 1980s by inves-1998b; Grill and Kaplan, 2002; Grill et al., 2002; Hosoi
et al., 2002). tigators who were screening small molecules and pep-
tides for their ability to increase growth hormone secre-Administration of exogenous leptin activates STAT-3
translocation, phosphorylation of phosphatidylinositol- tion (McCormick et al., 1985). They identified specific
peptides that they called growth hormone secreta-3-OH-kinase (PI3-K), and the expression of several
genes, including SOCS-3 and c-fos in neurons in hypo- gogues (GHSs) or growth hormone releasing peptides
(GHRPs), which could increase growth hormone secre-thalamic and brainstem cell groups that bear leptin re-
ceptors (Van Dijk et al., 1996; Woods and Stock, 1996; tion in a dose-dependent fashion in both rodents and
humans. These effects were not mediated by the knownElias et al., 1998a, 1999, 2000; Elmquist et al., 1997,
1998a; Bjorbaek et al., 1998; Hosoi et al., 2002; Hubschle growth hormone-releasing hormone receptor. The GHS
receptor was later identified (Pong et al., 1996; Smithet al., 2001; Niswender et al., 2001). Leptin-responsive
neurons in the arcuate nucleus include both those con- et al., 2001), but its endogenous ligand was only recently
discovered and named ghrelin (Bagnasco et al., 2002;taining neuropeptide Y (NPY) and agouti-related protein
(AgRP) in the medial part of the nucleus and those con- Horvath et al., 2001; Kojima et al., 1999; Nakazato et al.,
2001; Shintani et al., 2001; Tschop et al., 2000). Thistaining both pro-opiomelanocortin (POMC) and its deriv-
atives, including -melanocyte stimulating hormone hormone is synthesized in the stomach, and its levels
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Figure 2. A Summary Diagram Illustrating
Major Output Pathways by which Feeding Is
Regulated
Note that the parventricular (PVH) and arcu-
ate (ARC) hypothalamic nuclei and the lateral
hypothalamic area (LHA) provide the main de-
scending outputs that regulate autonomic,
endocrine, and motor responses that contrib-
ute to feeding. Projections back to the cere-
bral cortex that might control specific behav-
iors originate from the lateral hypothalamic
area and via a pathway from the nucleus ac-
cumbens (NAc) through the ventral pallidum
(VP) and mediodorsal thalamus (MDT) to pre-
frontal cortical areas, including the agranular insular (AIC) and infralimbic (ILC) cortical fields. AVP, arginine vasopressin; CART, cocaine and
amphetamine regulated transcript; CRH, corticotropin-releasing hormone; GABA, -amino butyric acid; MCH, melanin concentrating hormone;
ORX, orexin; POMC, pro-opiomelanocortin; TRH, thyrotropin-releasing hormone.
increase during food deprivation in animals (Kojima et et al., 2002a). Taken together, these observations sug-
gest that ghrelin plays a key role in the motivation foral., 1999) and peak prior to meals in humans (Cummings
et al., 2001, 2002b). Rising ghrelin levels in concert with feeding, but further work is needed to determine its
mechanisms of action and the CNS circuits throughfalling leptin levels may serve as a critical signal to in-
duce hunger during fasting. The interaction of these two which it exerts its effects.
Gastrointestinal Signaling of Satiety: Cholecystokinin,opposing nutritionally regulated hormones is currently
an area of active investigation. Glucagon-like Peptide-1, and Peptide YY
The brain receives a wide variety of signals from theThe site of action for ghrelin on feeding is thought to
be the hypothalamus, where ghrelin receptors are found gastrointestinal tract, via either sensory afferents or via
the circulation, at the dorsal vagal complex. Afferentin the ventromedial and arcuate nuclei (Guan et al., 1997;
Horvath et al., 2001), but ghrelin receptors are also lo- signals carried by the vagus nerve include indications
of gastric stretch as well as levels of glucose and lipidscated in other sites, and the actual mechanisms of action
remain to be established. In the arcuate nucleus, NPY/ in the liver. Sensory terminals carrying this information
terminate in the medial and dorsomedial parts of theAgRP neurons express ghrelin receptors (Willesen et
al., 1999), and ghrelin induces immediate early gene nucleus of the solitary tract. Some of these afferents
may end directly upon the distal dendrites of gastromo-expression in NPY neurons (Dickson and Luckman,
1997; Luckman et al., 1999). NPY antagonists blunt the tor vagal neurons, and others are relayed to the dorsal
motor vagal nucleus, which innervates the entire gastro-actions of ghrelin to induce feeding (Nakazato et al.,
2001; Tschop et al., 2000). However, NPY/ mice still intestinal tract.
Direct projections from the nucleus of the solitary tractrespond to ghrelin (Tschop et al., 2002), although some
of that response could be due to AgRP release from the and relayed inputs via the parabrachial nucleus inner-
vate the paraventricular, dorsomedial, and arcuate nu-same neurons (Broberger et al., 1998; Hahn et al., 1998).
It is currently controversial whether ghrelin is also used clei of the hypothalamus and the lateral hypothalamic
area; the central nucleus of the amygdala and bed nu-by neurons in the brain as a neuromodulator (Horvath
et al., 2001). Although several groups have reported that cleus of the stria terminalis; and the visceral sensory
thalamus (Saper, 2002). Information from the latter relayhypothalamic neurons display ghrelin-like immunoreac-
tivity or mRNA using rtPCR methods, the immunohisto- is transmitted to the visceral sensory cortex (see Saper,
2002), which is important for conscious appreciation ofchemical localizations conflict with one another, and in
situ hybridization studies have not confirmed the ex- gastrointestinal fullness. Individual neurons in the taste
portion of the visceral sensory cortex also may receivepression of ghrelin mRNA in hypothalamic neurons.
The role of ghrelin in motivating feeding is under- inputs concerned with gastric stretch (Cechetto and
Saper, 1987), which may be one mechanism for modulat-scored by recent studies in humans (Cummings et al.,
2001, 2002a, 2002b). Patients who had lost an average ing taste of food based upon satiety.
The area postrema is a circumventricular organ thatof 17% of their body weight via enforced dieting (and
who typically regain most of the weight when the diet lies directly above the nucleus of the solitary tract. Unlike
the nucleus of the solitary tract, which is protected fromwas ended) had significantly increased ghrelin levels
with exaggerated peaks in pre-meal ghrelin secretion sensing hormones directly by a blood-brain barrier, neu-
rons in the area postrema sit outside the blood-braincompared to obese controls. On the other hand, mor-
bidly obese patients who underwent a gastric bypass barrier (Broadwell and Brightman, 1976). Neurons in the
area postrema may respond to circulating gut hor-operation and who lost 36% of their body weight had
greatly reduced ghrelin levels, with loss of pre-meal mones, like cholecystokinin and GLP-1, and relay those
signals into the nucleus of the solitary tract and thepeaks in ghrelin secretion, and were much more suc-
cessful at maintaining their weight loss (Cummings et al., parabrachial nucleus (Herbert et al., 1990; Billig et al.,
2001; Rowlands et al., 1997; Rinaman et al., 1998).2002). Conversely, patients with Prader-Willi syndrome,
who have profound obesity and voracious and uncontroll- Recently, glucagon-like peptide-1 (GLP-1) has been
identified as a circulating hormone, produced by theable appetites, have remarkably high levels of ghrelin
when compared to other obese individuals (Cummings gut, which also can activate the area postrema and re-
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duce food intake. The pattern of Fos expression in the models (Lechan and Tatro, 2001; Marks and Cone, 2001;
Marks et al., 2001; Wisse et al., 2001).brain after intravenous administration of GLP-1 or a syn-
thetic agonist exendin demonstrates activation of the Which MC4-Rs are involved in regulating food intake
and body weight? One problem with assessing this sys-area postrema and some of the same pathways that are
thought to mediate vagal satiety signaling (Van Dijk et tem is that the receptors may be present not only on
the cell body and dendrites but also upon terminals.al., 1996; Yamamoto et al., 2002). However, if GLP-1
administration is paired with a novel flavorant, animals There is some evidence, for example, that the chief ef-
fect of -MSH on many PVH neurons may be mediatedwill subsequently avoid that flavor (Seeley et al., 2000;
Thiele et al., 1997; van Dijk et al., 1997). Conditioned by presynaptic MC4-Rs expressed by local GABAergic
interneurons (Cowley et al., 1999). MC4-R mRNA is ex-taste avoidance, which occurs with a single trial, is a very
important mechanism by which rodents avoid foods that pressed in several hypothalamic sites involved in regu-
lating feeding, including the PVH, LHA, and arcuate nu-have made them sick in the past. The fact that GLP-1
may serve as an unconditioned stimulus for a condi- cleus (Mountjoy et al., 1994; Kishi et al., 2002). In the
perifornical part of the LHA, which contains orexin andtioned taste avoidance suggests that GLP-1 may limit
feeding by inducing a sensation of sickness, such as MCH neurons, only a small subset of -MSH terminals
end upon these cell types (Elias et al., 1998b). However,nausea (Rinaman, 1999a, 1999b; Seeley et al., 2000;
Goldstone et al., 1997; Turton et al., 1996). This differ- if MC4-Rs were expressed by local interneurons that
provide inputs to the MCH and orexin neurons, the rela-ence is important, as the feeling of satiety after a meal
is generally experienced as rewarding, although the sen- tionship could only be discerned by intracellular electro-
physiology or electron microscopy. MC4-R mRNA issation of being overly full is unpleasant, and the two may
ultimately extinguish one another if food consumption is expressed in several extrahypothalamic sites as well.
For example, both parasympathetic and sympatheticnot tightly regulated.
Peptide YY (PYY) has recently been recognized as preganglionic neurons in the medulla and spinal cord
express MC4-R mRNA (Kishi et al., 2002). This observa-another gut hormone that may regulate food intake. PYY
is released from enteroendocrine cells in the small intes- tion is consistent with the observed autonomic effects
of MC4-R agonists on heart rate, blood pressure, insulintine and inhibits food intake in rodents and humans
(Batterham et al., 2002; Schwartz and Morton, 2002). levels, and insulin sensitivity. As leptin-activated POMC
neurons directly innervate sympathetic preganglionicAlthough the mechanism of action is not completely
understood, PYY appears to inhibit NPY/AgRP neurons neurons in the IML (Elias et al., 1998a), this pathway
may represent a simple circuit by which leptin may helpin the arcuate nucleus via Y2 receptors, and the ability
of PYY to inhibit feeding is abolished in Y2 receptor regulate blood pressure, energy expenditure, insulin se-
cretion, and insulin sensitivity (Minokoshi et al., 2002;knockout mice. The inhibition of NPY/AgRP neurons
may also disinhibit POMC/CART neurons in the arcuate Obici et al., 2001; Overton et al., 2001; Pelleymounter
et al., 1995).nucleus, which receive inhibitory collaterals from the
NPY/AgRP neurons (Batterham et al., 2002; Cowley et MC4-R mRNA is found in several other regions of the
brain thought to contribute to the regulation of feedingal., 2001). Thus, PYY may also serve as a circulating
satiety factor following ingestion of a meal. behavior. The nucleus accumbens (NAc) expresses
MC4-R mRNA (Kishi et al., 2002; Mountjoy et al., 1994)A Central Common Pathway for Inhibition
of Feeding: The Melanocortin System and innervates the LHA (Kirouac and Ganguly, 1995).
The predominant neurons in the NAc that project to theThe leptin-responsive POMC/CART neurons in the arcu-
ate nucleus are thought to cause anorexia and weight LHA are GABAergic, and these are thought to contribute
to the regulation of food intake (Stratford and Kelley,reduction by means of the actions of -MSH on melano-
cortin 3 and 4 receptors (MC3-Rs, MC4-Rs) (Marks and 1997, 1999). It is interesting that the orexic effects of a
single injection of AgRP may persist for up to 6 days (GrillCone, 2001). Because AgRP is an endogenous antago-
nist of -MSH at these same receptors, intracerebroven- et al., 1998; Hagan et al., 2001b) and are accompanied by
a distinct pattern of Fos expression in the NAc (Hagantricular administration of AgRP or overexpression of the
AgRP gene greatly increases food intake and body et al., 2001a). Thus, the melanocortin system may con-
tribute not only to the homeostatic control of feedingweight (Ollmann et al., 1997; Shutter et al., 1997).
The MC4-R is expressed predominantly in the CNS, but also to its hedonic aspects via the MC4-R input to
the NAc.and MC4-R blockade causes an obesity phenotype.
MC4-R/mice (Huszar et al., 1997) and humans (Farooqi Recent work also suggests that the effects of drugs
that act on the serotoninergic system may also be medi-et al., 2000; Vaisse et al., 1998; Yeo et al., 1998) and
mice lacking POMC are obese (Yaswen et al., 1999). ated at least in part via the MC4-R (Heisler et al., 2002).
d-Fenfluramine, which was widely used as part of theMutations that cause loss of function of the MC4-R (Far-
ooqi et al., 2000; Vaisse et al., 1998; Yeo et al., 1998) or Phen/Fen combination to cause weight loss in humans,
directly activates POMC neurons, probably via a seroto-POMC (Krude et al., 1998) genes in humans produce
obesity and insulin resistance, and up to 5% of morbidly nin 2c receptor mechanism. MC4-R antagonism blunts
the anorectic actions of d-Fen. Thus, the MC4-R mayobese humans may have spontaneous mutations in the
MC4-R gene (Barsh et al., 2000). In addition, the melano- play a key role in alterations of feeding and body weight
in patients taking serotonin reuptake inhibitors for de-cortin system may mediate the anorexia and weight loss
characteristic of illness and cancer cachexia models. pression and may be involved in the weight loss that
typically is seen in a variety of psychiatric disorders thatFor example, MC4-R/ mice are resistant to a variety
of models of cancer and cytokine-induced anorexia, and are thought to affect the serotonin system, including
depression and anorexia nervosa.AgRP is effective at increasing food intake in anorexia
Review
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A Central Common Pathway for Driving Feeding:
The Lateral Hypothalamic Orexin and Melanin
Concentrating Hormone Systems
The lateral hypothalamic area (LHA), including the peri-
fornical region, has been thought to play a key role in
the regulation of ingestive behavior since the early lesion
studies of Anand and Brobeck (Anand and Brobeck,
1951). In recent years, two peptides were discovered
that are expressed in the brain only by neurons in this
area: melanin concentrating hormone (MCH) and orexins Figure 3. A Summary Diagram Emphasizing the Relationship be-
(also known as hypocretins) (Bittencourt et al., 1992; tween the Nucleus Accumbens (NAc) and the Lateral Hypothalamic
Sakurai et al., 1998; de Lecea et al., 1998). The neurons Area (LHA)
containing these peptides are intermixed (but the pep- Cortical areas conveying sensory and behavioral influences on feed-
ing provide input to the NAc, whereas the LHA is the target oftides are not coexpressed; see Elias et al., 1998b; Brob-
homeostatic and circadian influences. Note that the LHA has aerger et al., 1998), and the cell groups that contain them
strong input to the NAc from neurons containing melanin-concen-have very similar and enormously wide-ranging projec-
trating hormone (MCH), which are believed to be excitatory for feed-tions (Chemelli et al., 1999; Bittencourt et al., 1992;
ing. In addition to a direct projection to the LHA, the NAc also gives
Peyron et al., 1998). The receptors for both peptides are rise to a GABergic pathway, through the ventral pallidum (VP), which
similarly widespread and very similar in their distribution is also GABAergic, that disinhibits feeding. This mutually reinforcing
(Marcus et al., 2001; Saito et al., 2001; Kilduff and de relationship may, under appropriate conditions, provide much of
the motivation for feeding.Lecea, 2001). Anatomical, physiological, and genetic
data support the view that these peptides play a key
role in driving feeding (Figure 2).
salivation, esophageal and gastric motility, gastric acidIntracerebroventricular injections of MCH increase
secretion, and regulation of the secretion of pancreaticfood intake in the rat, and MCH mRNA levels are in-
hormones, including insulin and glucagons (Ahren, 2000;creased by food deprivation. Leptin-deficient ob/ob
Katschinski, 2000). A third important target of the MCHmice have elevated levels of MCH mRNA (Qu et al.,
and orexin neurons are the monoaminergic cell groups,1996). Most persuasively, MCH/ mice are hypophagic
and lean, and mice that overexpress MCH are obese including the noradrenergic locus coeruleus, the seroto-
and hyperleptinemic (Ludwig et al., 2001; Shimada et ninergic dorsal and median raphe nuclei, and the hista-
al., 1998). The role of orexins in regulating food intake minergic tuberomammillary nucleus, which together
is less well defined, but icv injections of orexin increase constitute an ascending arousal system (Saper et al.,
feeding behavior, and food restriction increases orexin 2001). In addition, the MCH and orexin neurons provide
mRNA (Clegg et al., 2002; Sakurai et al., 1998). Moreover, a diffuse projection to the entire cerebral cortex. Al-
several recent studies have hypothesized a fundamental though it appears unlikely that the MCH and orexin neu-
role of orexin in coordinating endocrine and autonomic rons can directly produce a bout of feeding, they may
responses to falling glucose levels. For example, hypo- be able to enhance arousal and locomotor activity, thus
glycemia induces Fos expression in orexin neurons and increasing the likelihood that an animal will encounter
increases orexin mRNA expression (Cai et al., 1999; Grif- food, while priming consumatory pattern generators to
fond et al., 1999; Moriguchi et al., 1999). Hence, orexin lower the threshold for their activation if a likely food
neurons may represent one of the populations of “glu- source is identified.
cose-inhibited” neurons in the lateral hypothalamus that One of the few sites where the projections of the MCH
respond to physiological falls in glucose levels with an and orexin neurons differ is the nucleus accumbens,
increase in activity (Oomura and Yoshimatsu, 1984). which receives primarily an MCH input and bears mainly
The exact mechanisms by which these lateral hypo- MCH receptors (Peyron et al., 1998; Bittencourt et al.
thalamic neurons drive feeding have not been worked 1992; Saito et al., 2001; Marcus et al., 2001). As will be
out. However, MCH and orexin neurons have very similar described below, the nucleus accumbens is thought to
projection patterns, to a wide variety of structures that be involved in the rewarding aspects of feeding. By
are known to participate in feeding (Bittencourt et al., enhancing activity in the nucleus accumbens, the MCH
1992; Chemelli et al., 1999; Peyron et al., 1998). In addi- neurons may play a unique role in enhancing the hedonic
tion, MCH and orexin receptors are expressed in many value of food, and by receiving inputs from the nucleus
of these sites (Kilduff and de Lecea, 2001; Kokkotou et accumbens, they may participate in a self-reinforcing
al., 2001; Marcus et al., 2001; Saito et al., 2001). Major circuit that can support feeding (Figure 3).
targets of the MCH and orexin neurons include the brain-
stem motor systems that support behaviors like chew-
Hedonic Mechanisms for Regulating Feedinging, licking, and swallowing. These include cranial nerve
If feeding were controlled solely by homeostatic mecha-motor neurons in the trigeminal, facial, and hypoglossal
nisms, most of us would be at our ideal body weight,motor nuclei, as well as the reticular areas that surround
and people would consider feeding like breathing orthem and which constitute pattern generators for these
elimination, a necessary but unexciting part of exis-behaviors (Yamamoto et al., 1989; Lund et al., 1998;
tence. However, humans will pay large sums of moneyNakamura et al., 1999; Travers et al., 2000). The MCH
for an excellent meal (an indication that the food itselfand orexin neurons also innervate the sympathetic and
is rewarding, as money for most people is equivalent toparasympathetic preganglionic nuclei in the medulla
and the spinal cord. These sites are critical for promoting work expended), and almost any mammal will eat be-
Neuron
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yond its homeostatic needs if presented with highly pal- mic targets, including the lateral hypothalamic area (Al-
den et al., 1994; Bester et al., 1997, 1999; Cechetto andatable food. What makes certain foods rewarding be-
yond their metabolic content? Are there certain tastes Saper, 1987; Saper and Loewy, 1980). Early electrolytic
lesion studies suggested that the gustatory thalamusthat are intrinsically rewarding? And if so, how do these
tastes trigger brain responses that reinforce their con- was critical for hedonic aspects of taste, but more recent
studies using smaller, cell-specific lesions showed thatsumption?
Gustatory Mechanisms for Regulating Feeding after gustatory thalamic lesions, robust taste prefer-
ences and taste-conditioned behaviors persist (re-One unique quality of food reward is its strong modula-
tion by palatability cues, particularly taste and smell. viewed in Reilly, 1998). Hence, subcortical areas are
likely to play a critical role in mediating the motivationalAnimals will consume sweet and salty substances past
the need for homeostatic repletion, while even food- qualities of taste, but further research is needed to un-
derstand these potentially critical interactions.deprived animals will avoid substances that are highly
sour or bitter. These behaviors are of considerable adap- Reward System for Feeding
Motivation and reward have been studied most exten-tive value, as bitter tastes are often associated with toxic
alkaloids, while the acidity of many sour substances can sively in the context of drug addiction (Berke and Hy-
man, 2000; Wise, 1996; Laakso et al., 2002 [this issue ofindicate spoilage or unripeness, and sweet and salty
tastes indicate nutrients that are highly important for Neuron]) and intracranial self-stimulation (Milner, 1991;
Liebman, 1983; Wise, 2002 [this issue of Neuron]), wheresurvival. The value of a flavor is also potently modified
by postingestional cues. For example, administration of brain reward systems have been identified that allow the
reinforcement of responses that have no homeostaticlithium chloride (which induce feelings of illness) after
an animal has tasted a novel flavor results in one-trial value. However, a number of studies have suggested
that food rewards and drug rewards may share somelearning of a conditioned taste aversion to that flavor,
even one that would otherwise be highly preferred. Con- common neural substrates, including substantial evi-
dence that opioid receptors play key roles in both feed-ditioned taste aversion is also adaptive, as it allows
animals to avoid foods that have made them sick in the ing and reward (Kelley et al., 2002).
For example, opioid receptor antagonists such as nal-past. It suggests, also, that there must be potent circuitry
by which the gustatory hedonic value of flavors can be oxone block the effects of AgRP to increase feeding
(Hagan et al., 2001b). Recently, Hayward and colleaguesmodified.
There have recently been substantial advances in our (2002) reported that mice lacking either enkephalin or
-endorphin peptides showed a deficit in the ability ofunderstanding of taste discrimination at the molecular
level. Genes have been recently identified for a large food reward to increase bar pressing behavior, regard-
less of the palatability and nutrient content of the foodsnumber of taste receptors, including families of recep-
tors recognizing the classic four tastes (sweet, salty, examined. Interestingly, this response was abolished in
mice that were fasted prior to the trials. The authorssour, bitter) (Adler et al., 2000; Chandrashekar et al.,
2000; reviewed in Lindemann, 2001; Montmayeur et al., hypothesized that both peptides contribute to the rein-
forcing nature and hedonic value of food intake. More-2001; Nelson et al., 2001), as well as glutamate and
possibly other amino acids (Nelson et al., 2002). How- over, as this response is not observable following a fast,
homeostatic systems can override the opioid rewardever, it is not known how taste information ultimately
modulates feeding behaviors. Electrophysiological pathways during periods of energy insufficiency (Hay-
ward et al., 2002). Put another way, endogenous opioidstudies of individual taste cells in the tongue show that
a majority of taste cells respond to more than one of systems regulate the hedonic value of food intake inde-
pendently from the ongoing metabolic needs of the indi-the four classic tastes, and many respond to three or
four of these tastes (Gilbertson et al., 2001; Herness, vidual. Furthermore, food deprivation, which enhances
the hedonic response to food, also increases the motiva-2000). Similarly, primary afferent taste axons also show
a wide variety of response profiles (Scott and Giza, tional value of non-food rewards, such as psychostimu-
lants (Cabeza de Vaca and Carr, 1998), intracranial self-2000), as do taste-response neurons within brainstem
relay nuclei (Halsell and Travers, 1997; Smith et al., stimulation (Carr, 1996), and heroin intake (Shalev et al.,
2001).1983). Taken together, these findings argue against a
strict “labeled line” theory in which individual tastes The NAc and its dopaminergic inputs have been
strongly implicated in drug addiction (Di Chiara, 2000;would be passed through separate communication
channels. Rather, taste information appears to be en- Ikemoto and Panksepp, 1999; Roberts et al., 1980) and
intracranial self-stimulation (Garris et al., 1999; Milner,coded in a more complex “across-fiber” pattern, in
which basic tastes are conveyed by a variety of overlap- 1991), but early evidence did not show a similar involve-
ment of the NAc in food reward. Rats in which the nu-ping channels. Mechanisms by which pleasurable and
aversive cues are extracted from such diverse response cleus accumbens was ablated did not show obvious
reductions in food consumption (Ikemoto and Pank-profiles are unknown but represent an intriguing prob-
lem in sensory information coding. sepp, 1996; Koob et al., 1978), and such animals still
showed robust operant responding for food (BalleineTaste information passes through two brainstem re-
lays, the first located in the nucleus of the solitary tract and Killcross, 1994), leading to some speculation that
food rewards were not dopamine dependent. However,and the second in the parabrachial nucleus (Herbert et
al., 1990; Travers et al., 1987). The parabrachial nucleus more recent evidence has again argued for a dopaminer-
gic contribution to food reward. Mice that geneticallyin turn projects to a gustatory relay nucleus in the thala-
mus, as well as to the lateral frontal cerebral cortex, the lack the ability to produce dopamine normally die of
starvation. However, they resume feeding after introduc-central nucleus of the amygdala, and several hypothala-
Review
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tion of the tyrosine hydroxylase gene into the caudate- 2001), the DA response eventually habituates even
putamen (Szczypka et al., 2001), although introduction though animals continue to seek the reward long after
of this gene into the NAc alone is insufficient to restore this habituation occurs (Kiyatkin, 1995; Richardson and
feeding. Gratton, 1996; Schultz, 1998). Furthermore, as the DA
Pharmacological studies have also revived the notion response to rewarding stimuli habituates, DA responses
that the NAc plays an important role in regulating feeding become transferred to cues that anticipate and predict
behaviors, as feeding was potently induced by injections future rewards (Schultz, 1998, 2002 [this issue of Neu-
of opioid agonists, GABA agonists, glutamate antago- ron]). Hence, DA function has been proposed to be re-
nists, or nociceptin into the nucleus accumbens (Rey- lated more to novelty, attention, or anticipation than
nolds and Berridge, 2001; Stratford et al., 1997; Stratford to the immediate hedonic impact of the reward itself
and Kelley, 1997; Zhang and Kelley, 2000, 2002). These (Berridge and Robinson, 1998; Garris et al., 1999;
injections preferentially increased consumption of palat- Schultz, 1998, 2000; Montague and Berns, 2002 [this
able foods, such as sweet, salty, or fatty foods or liquids, issue of Neuron]). These emerging views of the DA sys-
over consumption of water or less palatable foods, sug- tem may help explain why lesions of DA neurons or the
gesting that increased food intake did not merely reflect NAc often did not reduce food consumption—in those
generalized increases in motor activity. Mu and kappa earlier studies, food was given ad libitum, and obtaining
opioid antagonist injections into the nucleus accumbens it did not require the instrumental goal-oriented behav-
inhibited feeding and sucrose intake, again with prefer- iors that are more closely associated with DA function.
ential reductions in the consumption of sucrose versus Non-dopaminergic systems also contribute impor-
less palatable substances (Bodnar et al., 1995; Kelley tantly to the reward value of food, including its immedi-
et al., 1996). Thus, NAc circuits may play an important ate hedonic impact. Non-dopaminergic mechanisms of
modulatory role, particularly in promoting the intake of reward have received considerably less study, but sero-
food that is hedonically desirable. tonin (5HT) has widely recognized influences on feeding
The mechanisms of NAc influences on feeding are and mood and may have important modulatory effects
not well understood. The NAc has extensive reciprocal on reward circuits and motivated behaviors (De Deur-
interactions with the LHA, which have been hypothe- waerdere et al., 1998; Fletcher et al., 1999; Pessia et
sized to regulate feeding behavior (Phillipson and Grif- al., 1994). As noted above, serotonin may also directly
fiths, 1985; Stratford and Kelley, 1999) (see Figure 3). influence POMC arcuate neurons involved in feeding
In addition, the main output target of the GABAergic via 5HT-2C receptors (Heisler et al., 2002). These POMC
neurons in the NAc is the ventral pallidum, which itself neurons may not only release -MSH but also -endor-
is GABAergic and targets the LHA (Groenewegen et al., phin, which acts at opiate receptors. A prominent ventral
1993). Thus, the NAc can disinhibit the LHA neurons, striatal role of opiates in food reward has been exten-
much as the striato-pallidal circuit disinhibits motor re- sively examined (Kelley et al., 2002), but given the wide
sponses. Feeding induced by injection of GABA antago- distribution of opioidergic neurons and receptors, opioid
nists into the NAc can be blocked by GABA antagonists pathways in other brain areas such as the hypothalamus
in the ventral pallidum as well as by GABA agonists in may also play a role. Finally, endogenous cannabinoids
the LHA (Maldonado-Irizarry et al., 1995; Stratford et also potently influence both appetite and reward in rats
al., 1999), while conversely, feeding induced by LHA and humans (Di Marzo et al., 2001; reviewed in Onaivi
stimulation can be blocked by DA blockade (Phillips and et al., 2002), but little is known about their mechanisms
Nikaido, 1975), suggesting that the striatal circuit plays of action.
a critical role in expressing feeding behavior. The NAc
contains very high levels of MCH receptor mRNA ex-
Interaction of Homeostatic and Hedonic Aspectspression (Saito et al., 2001) and MCH ligand binding
of Feedingsites (Borowsky et al., 2002) but not orexin, suggesting
Rewarding effects of food are potently modulated bythat the MCH neurons in the LHA play a critical role
internal states of the animal, such as homeostatic indica-in this relationship. In addition, the NAc may influence
tors of satiety. A food stimulus that is pleasurable whenfeeding behaviors via projections to the motor system,
one is hungry may be unpleasant after satiation, andincluding the substantia nigra pars reticulata, or to the
brain imaging studies support changes in amygdala andventral pallidum, which provides a long loop projection
orbitofrontal cortex activation that correlate with theseto the mediodorsal nucleus of the thalamus (Groene-
changes in subjective reports (Small et al., 2001; Zaldwegen et al., 1993) and then the prefrontal cortex. The
et al., 1998, 2002). Notably, leptin inhibits responses oflatter projection may guide the more complex planning
sweet-sensitive taste cells in the tongue (Kawai et al.,of behaviors that acquire or access foodstuffs.
2000), suggesting that leptin may mediate the hedonicAlthough DA and NAc mechanisms are widely be-
value on food reward beginning at the most peripherallieved to be involved in reward processes, it has become
level. Shizgal and colleagues also used the well estab-increasingly clear that the relationship between DA sys-
lished intracranial self-stimulation model to assess thetems and reward is much more complex than was ini-
ability of leptin to affect reward behavior. The periforni-tially appreciated. The idea that DA is equivalent to he-
cal part of the LHA, which contains the largest numbersdonic value is most likely oversimplified and has been
of orexin and MCH neurons, is a very sensitive site fromvigorously challenged and modified (Berridge and Rob-
which self-stimulation can be elicited. Interestingly,inson, 1998; Ikemoto and Panksepp, 1999; Kiyatkin,
chronic food restriction increased self-stimulation be-1995; Salamone et al., 1997; Schultz, 1998). Although
havior, whereas leptin administration blunted this in-DA release and DA neuron activity typically increase
when rewards are first presented (Hajnal and Norgren, crease (Fulton et al., 2000). Similarly, Shalev and co-
Neuron
206
Balleine, B., and Killcross, S. (1994). Effects of ibotenic acid lesionsworkers reported that leptin attenuates the ability of
of the nucleus accumbens on instrumental action. Behav. Brain Res.fasting to increase heroin-seeking behavior (Shalev et
65, 181–193.al., 2001). However, the specific leptin-responsive cell
Barsh, G.S., and Schwartz, M.W. (2002). Genetic approaches togroups mediating these effects are not known. In addi-
studying energy balance: perception and integration. Nat. Rev.
tion, although leptin is not believed to play a major role Genet. 3, 589–600.
in meal-to-meal regulation of feeding, the subjective
Barsh, G.S., Farooqi, I.S., and O’Rahilly, S. (2000). Genetics of body-
quality of a taste can change in a relatively short period weight regulation. Nature 404, 644–651.
(Small et al., 2001), suggesting that other faster- Batterham, R.L., Cowley, M.A., Small, C.J., Herzog, H., Cohen, M.A.,
responding homeostatic signals may also markedly alter Dakin, C.L., Wren, A.M., Brynes, A.E., Low, M.J., Ghatei, M.A., et al.
food rewards. Ghrelin, whose release from the stomach (2002). Gut hormone PYY(3–36) physiologically inhibits food intake.
Nature 418, 650–654.is increased by fasting, may be another potential homeo-
Berke, J.D., and Hyman, S.E. (2000). Addiction, dopamine, and thestatic signal that could affect food rewards, particularly
molecular mechanisms of memory. Neuron 25, 515–532.as its receptors have been identified in midbrain dopa-
Berridge, K.C., and Robinson, T.E. (1998). What is the role of dopa-minergic brain regions (Guan et al., 1997). It will be im-
mine in reward: hedonic impact, reward learning, or incentive sa-portant to determine the physiological mechanisms by
lience? Brain Res. Brain Res. Rev. 28, 309–369.which the rewarding nature of food may be modulated
Bester, H., Besson, J.M., and Bernard, J.F. (1997). Organization ofby ghrelin and other homeostatic signals, such as CCK,
efferent projections from the parabrachial area to the hypothalamus:peptide YY, blood glucose levels, insulin, GLP-1, and
a Phaseolus vulgaris-leucoagglutinin study in the rat. J. Comp. Neu-
perhaps visceral sensory inputs. rol. 383, 245–281.
In summary, a clear and comprehensive understand- Bester, H., Bourgeais, L., Villanueva, L., Besson, J.M., and Bernard,
ing of feeding-reward interactions is far from being real- J.F. (1999). Differential projections to the intralaminar and gustatory
ized, although many pieces of the overall puzzle are thalamus from the parabrachial area: a PHA-L study in the rat. J.
Comp. Neurol. 405, 421–449.becoming increasingly well understood. The last decade
Billig, I., Yates, B.J., and Rinaman, L. (2001). Plasma hormone levelshas seen considerable progress in unveiling hypothala-
and central c-Fos expression in ferrets after systemic administrationmic pathways that regulate homeostatic signals for
of cholecystokinin. Am. J. Physiol. Regul. Integr. Comp. Physiol.feeding, but less is understood about how these circuits
281, R1243–R1255.influence the ability of food to produce pleasure and
Bittencourt, J.C., Presse, F., Arias, C., Peto, C., Vaughan, J., Nahon,reward. Interactions between the LHA and NAc, as well
J.L., Vale, W., and Sawchenko, P.E. (1992). The melanin-concentrat-
as the interactions between DA, 5HT, and opioid sys- ing hormone system of the rat brain: an immuno- and hybridization
tems, are likely to play prominent roles, but the details histochemical characterization. J. Comp. Neurol. 319, 218–245.
of these interactions are not well understood. Food re- Bjorbaek, C., Elmquist, J.K., Frantz, J.D., Shoelson, S.E., and Flier,
wards are also strongly modulated by taste and satiety J.S. (1998). Identification of SOCS-3 as a potential mediator of cen-
tral leptin resistance. Mol. Cell 1, 619–625.cues, but the pathways by which these modulations
occur are also not well understood. Finally, the basic Bodnar, R.J., Glass, M.J., Ragnauth, A., and Cooper, M.L. (1995).
General, mu and kappa opioid antagonists in the nucleus accum-neural substrates of reward behaviors themselves re-
bens alter food intake under deprivation, glucoprivic and palatablemain a matter of debate, with a number of competing
conditions. Brain Res. 700, 205–212.interpretations of the functions of DA, 5HT, and related
Borowsky, B., Durkin, M.M., Ogozalek, K., Marzabadi, M.R., DeLeon,circuits. Although reward mechanisms have been most
J., Heurich, R., Lichtblau, H., Shaposhnik, Z., Daniewska, I., Black-
extensively studied in the context of drug addiction, burn, T.P., et al. (2002). Antidepressant, anxiolytic and anorectic
food rewards represent a more “natural” phenomenon effects of a melanin-concentrating hormone-1 receptor antagonist.
that may reflect everyday motivational and emotional Nat. Med. 8, 779–781.
processes more closely than drug-induced effects. Broadwell, R.D., and Brightman, M.W. (1976). Entry of peroxidase
Hence, further inquiry into the need to feed may provide into neurons of the central and peripheral nervous systems from
extracerebral and cerebral blood. J. Comp. Neurol. 166, 257–283.greater insight into the brain systems that underlie nor-
Broberger, C., De Lecea, L., Sutcliffe, J.G., and Hokfelt, T. (1998).mal everyday emotions and motivations.
Hypocretin/orexin- and melanin-concentrating hormone-expressing
cells form distinct populations in the rodent lateral hypothalamus:References
relationship to the neuropeptide Y and agouti gene-related protein
systems. J. Comp. Neurol. 402, 460–474.Adler, E., Hoon, M.A., Mueller, K.L., Chandrashekar, J., Ryba, N.J.,
and Zuker, C.S. (2000). A novel family of mammalian taste receptors. Cabeza de Vaca, S., and Carr, K.D. (1998). Food restriction enhances
Cell 100, 693–702. the central rewarding effect of abused drugs. J. Neurosci. 18, 7502–
7510.Ahima, R.S., Saper, C.B., Flier, J.S., and Elmquist, J.K. (2000). Leptin
regulation of neuroendocrine systems. Front. Neuroendocrinol. 21, Cai, X.J., Widdowson, P.S., Harrold, J., Wilson, S., Buckingham,
263–307. R.E., Arch, J.R., Tadayyon, M., Clapham, J.C., Wilding, J., and Wil-
liams, G. (1999). Hypothalamic orexin expression: modulation byAhren, B. (2000). Autonomic regulation of islet hormone secretion–
blood glucose and feeding. Diabetes 48, 2132–2137.implications for health and disease. Diabetologia 43, 393–410.
Campfield, L.A., Smith, F.J., Guisez, Y., Devos, R., and Burn, P.Alden, M., Besson, J.M., and Bernard, J.F. (1994). Organization of
(1995). Recombinant mouse OB protein: evidence for a peripheralthe efferent projections from the pontine parabrachial area to the
signal linking adiposity and central neural networks. Science 269,bed nucleus of the stria terminalis and neighboring regions: a PHA-
546–549.L study in the rat. J. Comp. Neurol. 341, 289–314.
Carr, K.D. (1996). Feeding, drug abuse, and the sensitization ofAnand, B.K., and Brobeck, J.R. (1951). Localization of a “feeding
reward by metabolic need. Neurochem. Res. 21, 1455–1467.center” in the hypothalamus of the rat. Proc. Soc. Exp. Biol. Med.
77, 323–324. Cechetto, D.F., and Saper, C.B. (1987). Evidence for a viscerotopic
sensory representation in the cortex and thalamus in the rat. J.Bagnasco, M., Kalra, P.S., and Kalra, S.P. (2002). Ghrelin and leptin
pulse discharge in fed and fasted rats. Endocrinology 143, 726–729. Comp. Neurol. 262, 27–45.
Review
207
Chandrashekar, J., Mueller, K.L., Hoon, M.A., Adler, E., Feng, L., pothalamus and the lateral hypothalamic area. J. Comp. Neurol.
402, 442–459.Guo, W., Zuker, C.S., and Ryba, N.J. (2000). T2Rs function as bitter
taste receptors. Cell 100, 703–711. Elias, C.F., Aschkenasi, C., Lee, C., Kelly, J., Ahima, R.S., Bjorbaek,
C., Flier, J.S., Saper, C.B., and Elmquist, J.K. (1999). Leptin differen-Chemelli, R.M., Willie, J.T., Sinton, C.M., Elmquist, J.K., Scammell,
tially regulates NPY and POMC neurons projecting to the lateralT., Lee, C., Richardson, J.A., Williams, S.C., Xiong, Y., Kisanuki, Y.,
hypothalamic area. Neuron 23, 775–786.et al. (1999). Narcolepsy in orexin knockout mice: molecular genetics
of sleep regulation. Cell 98, 437–451. Elias, C.F., Kelly, J.F., Lee, C.E., Ahima, R.S., Drucker, D.J., Saper,
C.B., and Elmquist, J.K. (2000). Chemical characterization of leptin-Chen, H., Charlat, O., Tartaglia, L.A., Woolf, E.A., Weng, X., Ellis,
activated neurons in the rat brain. J. Comp. Neurol. 423, 261–281.S.J., Lakey, N.D., Culpepper, J., Moore, K.J., Breitbart, R.E., et al.
(1996). Evidence that the diabetes gene encodes the leptin receptor: Elmquist, J.K., Ahima, R.S., Maratos-Flier, E., Flier, J.S., and Saper,
identification of a mutation in the leptin receptor gene in db/db mice. C.B. (1997). Leptin activates neurons in ventrobasal hypothalamus
Cell 84, 491–495. and brainstem. Endocrinology 138, 839–842.
Elmquist, J.K., Ahima, R.S., Elias, C.F., Flier, J.S., and Saper, C.B.Cheung, C.C., Clifton, D.K., and Steiner, R.A. (1997). Proopiomelano-
(1998a). Leptin activates distinct projections from the dorsomedialcortin neurons are direct targets for leptin in the hypothalamus.
and ventromedial hypothalamic nuclei. Proc. Natl. Acad. Sci. USAEndocrinology 138, 4489–4492.
95, 741–746.Chua, S.C., Jr., Chung, W.K., Wu-Peng, X.S., Zhang, Y., Liu, S.M.,
Elmquist, J.K., Bjorbaek, C., Ahima, R.S., Flier, J.S., and Saper, C.B.Tartaglia, L., and Leibel, R.L. (1996). Phenotypes of mouse diabetes
(1998b). Distributions of leptin receptor mRNA isoforms in the ratand rat fatty due to mutations in the OB (leptin) receptor. Science
brain. J. Comp. Neurol. 395, 535–547.271, 994–996.
Elmquist, J.K., Maratos-Flier, E., Saper, C.B., and Flier, J.S. (1998c).Clegg, D.J., Air, E.L., Woods, S.C., and Seeley, R.J. (2002). Eating
Unraveling the central nervous system pathways underlying re-elicited by orexin-a, but not melanin-concentrating hormone, is opi-
sponses to leptin. Nat. Neurosci. 1, 445–450.oid mediated. Endocrinology 143, 2995–3000.
Elmquist, J.K., Elias, C.F., and Saper, C.B. (1999). From lesions toCowley, M.A., Pronchuk, N., Fan, W., Dinulescu, D.M., Colmers,
leptin: hypothalamic control of food intake and body weight. NeuronW.F., and Cone, R.D. (1999). Integration of NPY, AGRP, and melano-
22, 221–232.cortin signals in the hypothalamic paraventricular nucleus: evidence
Farooqi, I.S., Yeo, G.S., Keogh, J.M., Aminian, S., Jebb, S.A., Butler,of a cellular basis for the adipostat. Neuron 24, 155–163.
G., Cheetham, T., and O’Rahilly, S. (2000). Dominant and recessive
Cowley, M.A., Smart, J.L., Rubinstein, M., Cerdan, M.G., Diano, S.,
inheritance of morbid obesity associated with melanocortin 4 recep-
Horvath, T.L., Cone, R.D., and Low, M.J. (2001). Leptin activates
tor deficiency. J. Clin. Invest. 106, 271–279.
anorexigenic POMC neurons through a neural network in the arcuate
Fei, H., Okano, H.J., Li, C., Lee, G.H., Zhao, C., Darnell, R., andnucleus. Nature 411, 480–484.
Friedman, J.M. (1997). Anatomic localization of alternatively spliced
Cummings, D.E., Purnell, J.Q., Frayo, R.S., Schmidova, K., Wisse, leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl.
B.E., and Weigle, D.S. (2001). A preprandial rise in plasma ghrelin Acad. Sci. USA 94, 7001–7005.
levels suggests a role in meal initiation in humans. Diabetes 50,
Fletcher, P.J., Korth, K.M., and Chambers, J.W. (1999). Selective1714–1719.
destruction of brain serotonin neurons by 5,7-dihydroxytryptamine
Cummings, D.E., Clement, K., Purnell, J.Q., Vaisse, C., Foster, K.E., increases responding for a conditioned reward. Psychopharmacol-
Frayo, R.S., Schwartz, M.W., Basdevant, A., and Weigle, D.S. ogy (Berl.) 147, 291–299.
(2002a). Elevated plasma ghrelin levels in Prader Willi syndrome.
Frederich, R.C., Hamann, A., Anderson, S., Lollmann, B., Lowell,Nat. Med. 8, 643–644.
B.B., and Flier, J.S. (1995a). Leptin levels reflect body lipid content
Cummings, D.E., Weigle, D.S., Frayo, R.S., Breen, P.A., Ma, M.K., in mice: evidence for diet-induced resistance to leptin action. Nat.
Dellinger, E.P., and Purnell, J.Q. (2002b). Plasma ghrelin levels after Med. 1, 1311–1314.
diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med.
Frederich, R.C., Lollmann, B., Hamann, A., Napolitano-Rosen, A.,
346, 1623–1630.
Kahn, B.B., Lowell, B.B., and Flier, J.S. (1995b). Expression of ob
De Deurwaerdere, P., Stinus, L., and Spampinato, U. (1998). Oppo- mRNA and its encoded protein in rodents. Impact of nutrition and
site change of in vivo dopamine release in the rat nucleus accum- obesity. J. Clin. Invest. 96, 1658–1663.
bens and striatum that follows electrical stimulation of dorsal raphe Friedman, J.M., and Halaas, J.L. (1998). Leptin and the regulation
nucleus: role of 5–HT3 receptors. J. Neurosci. 18, 6528–6538. of body weight in mammals. Nature 395, 763–770.
de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, Fulton, S., Woodside, B., and Shizgal, P. (2000). Modulation of brain
P.E., Fukuhara, C., Battenberg, E.L., Gautvik, V.T., Bartlett, F.S., II, reward circuitry by leptin. Science 287, 125–128.
et al. (1998). The hypocretins: hypothalamus-specific peptides with
Garris, P.A., Kilpatrick, M., Bunin, M.A., Michael, D., Walker, Q.D.,
neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95, 322–327.
and Wightman, R.M. (1999). Dissociation of dopamine release in the
Di Chiara, G. (2000). Role of dopamine in the behavioural actions nucleus accumbens from intracranial self-stimulation. Nature 398,
of nicotine related to addiction. Eur. J. Pharmacol. 393, 295–314. 67–69.
Dickson, S.L., and Luckman, S.M. (1997). Induction of c-fos messen- Gilbertson, T.A., Boughter, J.D., Jr., Zhang, H., and Smith, D.V.
ger ribonucleic acid in neuropeptide Y and growth hormone (GH)- (2001). Distribution of gustatory sensitivities in rat taste cells: whole-
releasing factor neurons in the rat arcuate nucleus following sys- cell responses to apical chemical stimulation. J. Neurosci. 21, 4931–
temic injection of the GH secretagogue, GH-releasing peptide-6. 4941.
Endocrinology 138, 771–777. Goldstone, A.P., Mercer, J.G., Gunn, I., Moar, K.M., Edwards, C.M.,
Rossi, M., Howard, J.K., Rasheed, S., Turton, M.D., Small, C., etDi Marzo, V., Goparaju, S.K., Wang, L., Liu, J., Batkai, S., Jarai, Z.,
al. (1997). Leptin interacts with glucagon-like peptide-1 neurons toFezza, F., Miura, G.I., Palmiter, R.D., Sugiura, T., and Kunos, G.
reduce food intake and body weight in rodents. FEBS Lett. 415,(2001). Leptin-regulated endocannabinoids are involved in main-
134–138.taining food intake. Nature 410, 822–825.
Griffond, B., Risold, P.Y., Jacquemard, C., Colard, C., and Fellmann,Elias, C.F., Lee, C., Kelly, J., Aschkenasi, C., Ahima, R.S., Couceyro,
D. (1999). Insulin-induced hypoglycemia increases preprohypocre-P.R., Kuhar, M.J., Saper, C.B., and Elmquist, J.K. (1998a). Leptin
tin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci.activates hypothalamic CART neurons projecting to the spinal cord.
Lett. 262, 77–80.Neuron 21, 1375–1385.
Grill, H.J., and Kaplan, J.M. (2002). The neuroanatomical axis forElias, C.F., Saper, C.B., Maratos-Flier, E., Tritos, N.A., Lee, C., Kelly,
control of energy balance. Front. Neuroendocrinol. 23, 2–40.J., Tatro, J.B., Hoffman, G.E., Ollmann, M.M., Barsh, G.S., et al.
(1998b). Chemically defined projections linking the mediobasal hy- Grill, H.J., Ginsberg, A.B., Seeley, R.J., and Kaplan, J.M. (1998).
Neuron
208
Brainstem application of melanocortin receptor ligands produces tions of reward-relevant brain regions. Behav. Neurosci. 110,
331–345.long-lasting effects on feeding and body weight. J. Neurosci. 18,
10128–10135. Ikemoto, S., and Panksepp, J. (1999). The role of nucleus accumbens
dopamine in motivated behavior: a unifying interpretation with spe-Grill, H.J., Schwartz, M.W., Kaplan, J.M., Foxhall, J.S., Breininger,
cial reference to reward-seeking. Brain Res. Brain Res. Rev. 31,J., and Baskin, D.G. (2002). Evidence that the caudal brainstem is
6–41.a target for the inhibitory effect of leptin on food intake. Endocrinol-
ogy 143, 239–246. Katschinski, M. (2000). Nutritional implications of cephalic phase
gastrointestinal responses. Appetite 34, 189–196.Groenewegen, H.J., Berendse, H.W., and Haber, S.N. (1993). Organi-
zation of the output of the ventral striatopallidal system in the rat: Kawai, K., Sugimoto, K., Nakashima, K., Miura, H., and Ninomiya,
ventral pallidal efferents. Neuroscience 57, 113–142. Y. (2000). Leptin as a modulator of sweet taste sensitivities in mice.
Proc. Natl. Acad. Sci. USA 97, 11044–11049.Guan, X.M., Yu, H., Palyha, O.C., McKee, K.K., Feighner, S.D., Siri-
nathsinghji, D.J., Smith, R.G., Van der Ploeg, L.H., and Howard, Kelley, A.E., Bless, E.P., and Swanson, C.J. (1996). Investigation of
A.D. (1997). Distribution of mRNA encoding the growth hormone the effects of opiate antagonists infused into the nucleus accum-
secretagogue receptor in brain and peripheral tissues. Brain Res. bens on feeding and sucrose drinking in rats. J. Pharmacol. Exp.
Mol. Brain Res. 48, 23–29. Ther. 278, 1499–1507.
Hagan, M.M., Benoit, S.C., Rushing, P.A., Pritchard, L.M., Woods, Kelley, A.E., Bakshi, V.P., Haber, S.N., Steininger, T.L., Will, M.J.,
S.C., and Seeley, R.J. (2001a). Immediate and prolonged patterns and Zhang, M. (2002). Opioid modulation of taste hedonics within
of agouti-related peptide-(83–132)-induced c-Fos activation in hy- the ventral striatum. Physiol. Behav. 76, 365–377.
pothalamic and extrahypothalamic sites. Endocrinology 142, 1050– Kilduff, T.S., and de Lecea, L. (2001). Mapping of the mRNAs for the
1056. hypocretin/orexin and melanin-concentrating hormone receptors:
Hagan, M.M., Rushing, P.A., Benoit, S.C., Woods, S.C., and Seeley, networks of overlapping peptide systems. J. Comp. Neurol. 435,
R.J. (2001b). Opioid receptor involvement in the effect of AgRP- 1–5.
(83–132) on food intake and food selection. Am. J. Physiol. Regul. Kirouac, G.J., and Ganguly, P.K. (1995). Topographical organization
Integr. Comp. Physiol. 280, R814–R821. in the nucleus accumbens of afferents from the basolateral amyg-
Hahn, T.M., Breininger, J.F., Baskin, D.G., and Schwartz, M.W. dala and efferents to the lateral hypothalamus. Neuroscience 67,
(1998). Coexpression of Agrp and NPY in fasting-activated hypothal- 625–630.
amic neurons. Nat. Neurosci. 1, 271–272. Kishi, T., Aschkenasi, C.J., Lee, C.E., Mountjoy, K.G., Saper, C.B.,
Hajnal, A., and Norgren, R. (2001). Accumbens dopamine mecha- and Elmquist, J.K (2002). Expression of melanocortin 4 receptor
nisms in sucrose intake. Brain Res. 904, 76–84. mRNA in the central nervous system of the rat. J. Comp. Neurol.,
in press.Hakansson, M.L., Hulting, A.L., and Meister, B. (1996). Expression
of leptin receptor mRNA in the hypothalamic arcuate nucleus– Kiyatkin, E.A. (1995). Functional significance of mesolimbic dopa-
relationship with NPY neurones. Neuroreport 7, 3087–3092. mine. Neurosci. Biobehav. Rev. 19, 573–598.
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., andHalaas, J.L., Gajiwala, K.S., Maffei, M., Cohen, S.L., Chait, B.T.,
Rabinowitz, D., Lallone, R.L., Burley, S.K., and Friedman, J.M. (1995). Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated
peptide from stomach. Nature 402, 656–660.Weight-reducing effects of the plasma protein encoded by the obese
gene. Science 269, 543–546. Kokkotou, E.G., Tritos, N.A., Mastaitis, J.W., Slieker, L., and Maratos-
Flier, E. (2001). Melanin-concentrating hormone receptor is a targetHalsell, C.B., and Travers, S.P. (1997). Anterior and posterior oral
of leptin action in the mouse brain. Endocrinology 142, 680–686.cavity responsive neurons are differentially distributed among para-
brachial subnuclei in rat. J. Neurophysiol. 78, 920–938. Koob, G.F., Riley, S.J., Smith, S.C., and Robbins, T.W. (1978). Effects
of 6-hydroxydopamine lesions of the nucleus accumbens septi andHayward, M.D., Pintar, J.E., and Low, M.J. (2002). Selective reward
olfactory tubercle on feeding, locomotor activity, and amphetaminedeficit in mice lacking Beta-endorphin and enkephalin. J. Neurosci.
anorexia in the rat. J. Comp. Physiol. Psychol. 92, 917–927.22, 8251–8258.
Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., andHeisler, L.K., Cowley, M.A., Tecott, L.H., Fan, W., Low, M.J., Smart,
Gruters, A. (1998). Severe early-onset obesity, adrenal insufficiencyJ.L., Rubinstein, M., Tatro, J.B., Marks, L., Holstege, H., et al. (2002).
and red hair pigmentation caused by POMC mutations in humans.Activation of central melanocortin pathways by fenfluramine. Sci-
Nat. Genet. 19, 155–157.ence 297, 609–611.
Laakso, A., Mohn, A.R., Gainetdinov, R.R., and Caron, M.G. (2002).Herbert, H., Moga, M.M., and Saper, C.B. (1990). Connections of
Experimental genetic approaches to addiction. Neuron 36, this is-the parabrachial nucleus with the nucleus of the solitary tract and
sue, 213–228.the medullary reticular formation in the rat. J. Comp. Neurol. 293,
540–580. Lechan, R.M., and Tatro, J.B. (2001). Hypothalamic melanocortin
signaling in cachexia. Endocrinology 142, 3288–3291.Herness, S. (2000). Coding in taste receptor cells. The early years
of intracellular recordings. Physiol. Behav. 69, 17–27. Lee, G.H., Proenca, R., Montez, J.M., Carroll, K.M., Darvishzadeh,
J.G., Lee, J.I., and Friedman, J.M. (1996). Abnormal splicing of theHorvath, T.L., Diano, S., Sotonyi, P., Heiman, M., and Tschop, M.
leptin receptor in diabetic mice. Nature 379, 632–635.(2001). Minireview: ghrelin and the regulation of energy balance–a
hypothalamic perspective. Endocrinology 142, 4163–4169. Liebman, J.M. (1983). Discriminating between reward and perfor-
mance: a critical review of intracranial self-stimulation methodology.Hosoi, T., Kawagishi, T., Okuma, Y., Tanaka, J., and Nomura, Y.
Neurosci. Biobehav. Rev. 7, 45–72.(2002). Brain stem is a direct target for leptin’s action in the central
nervous system. Endocrinology 143, 3498–3504. Lindemann, B. (2001). Receptors and transduction in taste. Nature
413, 219–225.Hubschle, T., Thom, E., Watson, A., Roth, J., Klaus, S., and Meyerhof,
W. (2001). Leptin-induced nuclear translocation of STAT3 immuno- Luckman, S.M., Rosenzweig, I., and Dickson, S.L. (1999). Activation
reactivity in hypothalamic nuclei involved in body weight regulation. of arcuate nucleus neurons by systemic administration of leptin
J. Neurosci. 21, 2413–2424. and growth hormone-releasing peptide-6 in normal and fasted rats.
Neuroendocrinology 70, 93–100.Huszar, D., Lynch, C.A., Fairchild-Huntress, V., Dunmore, J.H., Fang,
Q., Berkemeier, L.R., Gu, W., Kesterson, R.A., Boston, B.A., Cone, Ludwig, D.S., Tritos, N.A., Mastaitis, J.W., Kulkarni, R., Kokkotou,
R.D., et al. (1997). Targeted disruption of the melanocortin-4 recep- E., Elmquist, J., Lowell, B., Flier, J.S., and Maratos-Flier, E. (2001).
tor results in obesity in mice. Cell 88, 131–141. Melanin-concentrating hormone overexpression in transgenic mice
leads to obesity and insulin resistance. J. Clin. Invest. 107, 379–386.Ikemoto, S., and Panksepp, J. (1996). Dissociations between appeti-
tive and consummatory responses by pharmacological manipula- Lund, J.P., Kolta, A., Westberg, K.G., and Scott, G. (1998). Brainstem
Review
209
mechanisms underlying feeding behaviors. Curr. Opin. Neurobiol. shola, B.E., and Uhl, G.R. (2002). Endocannabinoids and canna-
binoid receptor genetics. Prog. Neurobiol. 66, 307–344.8, 718–724.
Maffei, M., Halaas, J., Ravussin, E., Pratley, R.E., Lee, G.H., Zhang, Oomura, Y., and Yoshimatsu, H. (1984). Neural network of glucose
Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995). Leptin monitoring system. J. Auton. Nerv. Syst. 10, 359–372.
levels in human and rodent: measurement of plasma leptin and ob Overton, J.M., Williams, T.D., Chambers, J.B., and Rashotte, M.E.
RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155–1161. (2001). Central leptin infusion attenuates the cardiovascular and
Maldonado-Irizarry, C.S., Swanson, C.J., and Kelley, A.E. (1995). metabolic effects of fasting in rats. Hypertension 37, 663–669.
Glutamate receptors in the nucleus accumbens shell control feeding Pelleymounter, M.A., Cullen, M.J., Baker, M.B., Hecht, R., Winters,
behavior via the lateral hypothalamus. J. Neurosci. 15, 6779–6788. D., Boone, T., and Collins, F. (1995). Effects of the obese gene
Marcus, J.N., Aschkenasi, C.J., Lee, C.E., Chemelli, R.M., Saper, product on body weight regulation in ob/ob mice. Science 269,
C.B., Yanagisawa, M., and Elmquist, J.K. (2001). Differential expres- 540–543.
sion of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. Pessia, M., Jiang, Z.G., North, R.A., and Johnson, S.W. (1994). Ac-
435, 6–25. tions of 5-hydroxytryptamine on ventral tegmental area neurons of
Marks, D.L., and Cone, R.D. (2001). Central melanocortins and the the rat in vitro. Brain Res. 654, 324–330.
regulation of weight during acute and chronic disease. Recent Prog. Peyron, C., Tighe, D.K., van den Pol, A.N., de Lecea, L., Heller,
Horm. Res. 56, 359–375. H.C., Sutcliffe, J.G., and Kilduff, T.S. (1998). Neurons containing
Marks, D.L., Ling, N., and Cone, R.D. (2001). Role of the central hypocretin (orexin) project to multiple neuronal systems. J. Neurosci.
melanocortin system in cachexia. Cancer Res. 61, 1432–1438. 18, 9996–10015.
McCormick, G.F., Millard, W.J., Badger, T.M., Bowers, C.Y., and Phillips, A.G., and Nikaido, R.S. (1975). Disruption of brain stimula-
Martin, J.B. (1985). Dose-response characteristics of various pep- tion-induced feeding by dopamine receptor blockade. Nature 258,
tides with growth hormone-releasing activity in the unanesthetized 750–751.
male rat. Endocrinology 117, 97–105. Phillipson, O.T., and Griffiths, A.C. (1985). The topographic order of
Mercer, J.G., Hoggard, N., Williams, L.M., Lawrence, C.B., Hannah, inputs to nucleus accumbens in the rat. Neuroscience 16, 275–296.
L.T., and Trayhurn, P. (1996). Localization of leptin receptor mRNA Pong, S.S., Chaung, L.Y., Dean, D.C., Nargund, R.P., Patchett, A.A.,
and the long form splice variant (Ob-Rb) in mouse hypothalamus and Smith, R.G. (1996). Identification of a new G-protein-linked re-
and adjacent brain regions by in situ hybridization. FEBS Lett. 387, ceptor for growth hormone secretagogues. Mol. Endocrinol. 10,
113–116. 57–61.
Milner, P.M. (1991). Brain-stimulation reward: a review. Can. J. Psy- Qu, D., Ludwig, D.S., Gammeltoft, S., Piper, M., Pelleymounter, M.A.,
chol. 45, 1–36. Cullen, M.J., Mathes, W.F., Przypek, R., Kanarek, R., and Maratos-
Minokoshi, Y., Kim, Y.B., Peroni, O.D., Fryer, L.G., Muller, C., Carling, Flier, E. (1996). A role for melanin-concentrating hormone in the
D., and Kahn, B.B. (2002). Leptin stimulates fatty-acid oxidation by central regulation of feeding behaviour. Nature 380, 243–247.
activating AMP-activated protein kinase. Nature 415, 339–343. Reilly, S. (1998). The role of the gustatory thalamus in taste-guided
Montague, P.R., and Berns, G.S. (2002). Neural economics and bio- behavior. Neurosci. Biobehav. Rev. 22, 883–901.
logical substrates of valuation. Neuron 36, this issue, 265–284. Reynolds, S.M., and Berridge, K.C. (2001). Fear and feeding in the
Montmayeur, J.P., Liberles, S.D., Matsunami, H., and Buck, L.B. nucleus accumbens shell: rostrocaudal segregation of GABA-elic-
(2001). A candidate taste receptor gene near a sweet taste locus. ited defensive behavior versus eating behavior. J. Neurosci. 21,
Nat. Neurosci. 4, 492–498. 3261–3270.
Moriguchi, T., Sakurai, T., Nambu, T., Yanagisawa, M., and Goto, Richardson, N.R., and Gratton, A. (1996). Behavior-relevant changes
K. (1999). Neurons containing orexin in the lateral hypothalamic in nucleus accumbens dopamine transmission elicited by food rein-
area of the adult rat brain are activated by insulin-induced acute forcement: an electrochemical study in rat. J. Neurosci. 16, 8160–
hypoglycemia. Neurosci. Lett. 264, 101–104. 8169.
Mountjoy, K.G., Mortrud, M.T., Low, M.J., Simerly, R.B., and Cone, Rinaman, L. (1999a). A functional role for central glucagon-like pep-
R.D. (1994). Localization of the melanocortin-4 receptor (MC4-R) in tide-1 receptors in lithium chloride-induced anorexia. Am. J. Physiol.
neuroendocrine and autonomic control circuits in the brain. Mol. 277, R1537–R1540.
Endocrinol. 8, 1298–1308. Rinaman, L. (1999b). Interoceptive stress activates glucagon-like
Nakamura, Y., Katakura, N., and Nakajima, N. (1999). Generation of peptide-1 neurons that project to the hypothalamus. Am. J. Physiol.
rhythmical ingestive activities of the trigeminal, facial, and hypoglos- 277, R582–R590.
sal motoneurons in in vitro CNS preparations isolated from rats and Rinaman, L., Baker, E.A., Hoffman, G.E., Stricker, E.M., and Verbalis,
mice. J. Med. Dent. Sci. 46, 63–73. J.G. (1998). Medullary c-Fos activation in rats after ingestion of a
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kan- satiating meal. Am. J. Physiol. 275, R262–R268.
gawa, K., and Matsukura, S. (2001). A role for ghrelin in the central Roberts, D.C., Koob, G.F., Klonoff, P., and Fibiger, H.C. (1980). Ex-
regulation of feeding. Nature 409, 194–198. tinction and recovery of cocaine self-administration following
Nelson, G., Hoon, M.A., Chandrashekar, J., Zhang, Y., Ryba, N.J., 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol.
and Zuker, C.S. (2001). Mammalian sweet taste receptors. Cell 106, Biochem. Behav. 12, 781–787.
381–390. Rowlands, N.E., Crews, E.C., and Gentry, R.M. (1997). Comparison
Nelson, G., Chandrashekar, J., Hoon, M.A., Feng, L., Zhao, G., Ryba, of Fos induced in rat brain by GLP-1 and amylin. Regul. Pept. 71,
N.J., and Zuker, C.S. (2002). An amino-acid taste receptor. Nature 171–174.
416, 199–202. Saito, Y., Cheng, M., Leslie, F.M., and Civelli, O. (2001). Expression
Niswender, K.D., Morton, G.J., Stearns, W.H., Rhodes, C.J., Myers, of the melanin-concentrating hormone (MCH) receptor mRNA in the
M.G., Jr., and Schwartz, M.W. (2001). Intracellular signalling. Key rat brain. J. Comp. Neurol. 435, 26–40.
enzyme in leptin-induced anorexia. Nature 413, 794–795. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M.,
Obici, S., Feng, Z., Tan, J., Liu, L., Karkanias, G., and Rossetti, L. Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson,
(2001). Central melanocortin receptors regulate insulin action. J. S., et al. (1998). Orexins and orexin receptors: a family of hypothala-
Clin. Invest. 108, 1079–1085. mic neuropeptides and G protein-coupled receptors that regulate
feeding behavior. Cell 92, 573–585.Ollmann, M.M., Wilson, B.D., Yang, Y.K., Kerns, J.A., Chen, Y., Gantz,
I., and Barsh, G.S. (1997). Antagonism of central melanocortin recep- Salamone, J.D., Cousins, M.S., and Snyder, B.J. (1997). Behavioral
tors in vitro and in vivo by agouti-related protein. Science 278, functions of nucleus accumbens dopamine: empirical and concep-
135–138. tual problems with the anhedonia hypothesis. Neurosci. Biobehav.
Rev. 21, 341–359.Onaivi, E.S., Leonard, C.M., Ishiguro, H., Zhang, P.W., Lin, Z., Akin-
Neuron
210
Saper, C.B. (2002). The central autonomic nervous system: Con- nociceptin into nucleus accumbens shell or ventromedial hypothala-
mic nucleus increase food intake. Neuroreport 8, 423–426.scious visceral perception and autonomic pattern generation. Annu.
Rev. Neurosci. 25, 433–469. Stratford, T.R., Kelley, A.E., and Simansky, K.J. (1999). Blockade of
GABA-A receptors in the medial ventral pallidum elicits feeding inSaper, C.B., and Loewy, A.D. (1980). Efferent connections of the
parabrachial nucleus in the rat. Brain Res. 197, 291–317. satiated rats. Brain Res. 825, 199–203.
Szczypka, M.S., Kwok, K., Brot, M.D., Marck, B.T., Matsumoto, A.M.,Saper, C.B., Chou, T.C., and Scammell, T.E. (2001). The sleep switch:
hypothalamic control of sleep and wakefulness. Trends Neurosci. Donahue, B.A., and Palmiter, R.D. (2001). Dopamine production in
the caudate putamen restores feeding in dopamine-deficient mice.24, 726–731.
Neuron 30, 819–828.Schultz, W. (1998). Predictive reward signal of dopamine neurons.
J. Neurophysiol. 80, 1–27. Tartaglia, L.A. (1997). The leptin receptor. J. Biol. Chem. 272, 6093–
6096.Schultz, W. (2002). Getting formal with dopamine and reward. Neu-
ron 36, this issue, 241–263. Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J.,
Devos, R., Richards, G.J., Campfield, L.A., Clark, F.T., Deeds, J., etSchwartz, M.W., and Morton, G.J. (2002). Obesity: keeping hunger
al. (1995). Identification and expression cloning of a leptin receptor,at bay. Nature 418, 595–597.
OB-R. Cell 83, 1263–1271.
Schwartz, M.W., Seeley, R.J., Campfield, L.A., Burn, P., and Baskin,
Thiele, T.E., Van Dijk, G., Campfield, L.A., Smith, F.J., Burn, P.,D.G. (1996). Identification of targets of leptin action in rat hypothala-
Woods, S.C., Bernstein, I.L., and Seeley, R.J. (1997). Central infusionmus. J. Clin. Invest. 98, 1101–1106.
of GLP-1, but not leptin, produces conditioned taste aversions in
Schwartz, M.W., Woods, S.C., Porte, D., Jr., Seeley, R.J., and Baskin,
rats. Am. J. Physiol. 272, R726–R730.
D.G. (2000). Central nervous system control of food intake. Nature
Travers, J.B., Travers, S.P., and Norgren, R. (1987). Gustatory neural404, 661–671.
processing in the hindbrain. Annu. Rev. Neurosci. 10, 595–632.
Scott, T.R., and Giza, B.K. (2000). Issues of gustatory neural coding:
Travers, J.B., DiNardo, L.A., and Karimnamazi, H. (2000). Medullarywhere they stand today. Physiol. Behav. 69, 65–76.
reticular formation activity during ingestion and rejection in the
Seeley, R.J., Blake, K., Rushing, P.A., Benoit, S., Eng, J., Woods,
awake rat. Exp. Brain Res. 130, 78–92.
S.C., and D’Alessio, D. (2000). The role of CNS glucagon-like pep-
Tschop, M., Smiley, D.L., and Heiman, M.L. (2000). Ghrelin inducestide-1 (7–36) amide receptors in mediating the visceral illness effects
adiposity in rodents. Nature 407, 908–913.of lithium chloride. J. Neurosci. 20, 1616–1621.
Tschop, M., Statnick, M.A., Suter, T.M., and Heiman, M.L. (2002).Shalev, U., Yap, J., and Shaham, Y. (2001). Leptin attenuates acute
GH-releasing peptide-2 increases fat mass in mice lacking NPY:food deprivation-induced relapse to heroin seeking. J. Neurosci. 21,
indication for a crucial mediating role of hypothalamic agouti-relatedRC129.
protein. Endocrinology 143, 558–568.
Shimada, M., Tritos, N.A., Lowell, B.B., Flier, J.S., and Maratos-
Turton, M.D., O’Shea, D., Gunn, I., Beak, S.A., Edwards, C.M.,Flier, E. (1998). Mice lacking melanin-concentrating hormone are
Meeran, K., Choi, S.J., Taylor, G.M., Heath, M.M., Lambert, P.D., ethypophagic and lean. Nature 396, 670–674.
al. (1996). A role for glucagon-like peptide-1 in the central regulation
Shintani, M., Ogawa, Y., Ebihara, K., Aizawa-Abe, M., Miyanaga, F.,
of feeding. Nature 379, 69–72.
Takaya, K., Hayashi, T., Inoue, G., Hosoda, K., Kojima, M., et al.
Vaisse, C., Clement, K., Guy-Grand, B., and Froguel, P. (1998). A(2001). Ghrelin, an endogenous growth hormone secretagogue, is
frameshift mutation in human MC4R is associated with a dominanta novel orexigenic peptide that antagonizes leptin action through
form of obesity. Nat. Genet. 20, 113–114.the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.
Diabetes 50, 227–232. Van Dijk, G., Thiele, T.E., Donahey, J.C., Campfield, L.A., Smith, F.J.,
Burn, P., Bernstein, I.L., Woods, S.C., and Seeley, R.J. (1996). CentralShutter, J.R., Graham, M., Kinsey, A.C., Scully, S., Luthy, R., and
infusions of leptin and GLP-1-(7–36) amide differentially stimulateStark, K.L. (1997). Hypothalamic expression of ART, a novel gene
c-FLI in the rat brain. Am. J. Physiol. 271, R1096–R1100.related to agouti, is up-regulated in obese and diabetic mutant mice.
Genes Dev. 11, 593–602. van Dijk, G., Thiele, T.E., Seeley, R.J., Woods, S.C., and Bernstein,
I.L. (1997). Glucagon-like peptide-1 and satiety. Nature 385, 214.Small, D.M., Zatorre, R.J., Dagher, A., Evans, A.C., and Jones-Got-
man, M. (2001). Changes in brain activity related to eating chocolate: Willesen, M.G., Kristensen, P., and Romer, J. (1999). Co-localization
of growth hormone secretagogue receptor and NPY mRNA in thefrom pleasure to aversion. Brain 124, 1720–1733.
arcuate nucleus of the rat. Neuroendocrinology 70, 306–316.Smith, D.V., Van Buskirk, R.L., Travers, J.B., and Bieber, S.L. (1983).
Gustatory neuron types in hamster brain stem. J. Neurophysiol. 50, Wise, R.A. (1996). Addictive drugs and brain stimulation reward.
Annu. Rev. Neurosci. 19, 319–340.522–540.
Smith, R.G., Leonard, R., Bailey, A.R., Palyha, O., Feighner, S., Tan, Wise, R.A. (2002). Brain reward mechanisms: insights from unsensed
incentives. Neuron 36, this issue, 229–240.C., McKee, K.K., Pong, S.S., Griffin, P., and Howard, A. (2001).
Growth hormone secretagogue receptor family members and li- Wisse, B.E., Frayo, R.S., Schwartz, M.W., and Cummings, D.E.
gands. Endocrine 14, 9–14. (2001). Reversal of cancer anorexia by blockade of central melano-
cortin receptors in rats. Endocrinology 142, 3292–3301.Spanswick, D., Smith, M.A., Groppi, V.E., Logan, S.D., and Ashford,
M.L. (1997). Leptin inhibits hypothalamic neurons by activation of Woods, A.J., and Stock, M.J. (1996). Leptin activation in hypothala-
ATP-sensitive potassium channels. Nature 390, 521–525. mus. Nature 381, 745.
Spanswick, D., Smith, M.A., Mirshamsi, S., Routh, V.H., and Ashford, Woods, S.C., Seeley, R.J., Porte, D., Jr., and Schwartz, M.W. (1998).
M.L. (2000). Insulin activates ATP-sensitive K channels in hypothal- Signals that regulate food intake and energy homeostasis. Science
amic neurons of lean, but not obese rats. Nat. Neurosci. 3, 757–758. 280, 1378–1383.
Spiegelman, B.M., and Flier, J.S. (2001). Obesity and the regulation Yamamoto, T., Matsuo, R., Kiyomitsu, Y., and Kitamura, R. (1989).
of energy balance. Cell 104, 531–543. Sensory and motor responses of trigeminal and reticular neurons
during ingestive behavior in rats. Exp. Brain Res. 76, 386–400.Stratford, T.R., and Kelley, A.E. (1997). GABA in the nucleus accum-
bens shell participates in the central regulation of feeding behavior. Yamamoto, H., Lee, C.E., Marcus, J.N., Williams, T.D., Overton, J.M.,
J. Neurosci. 17, 4434–4440. Lopez, M.E., Hollenberg, A.N., Baggio, L., Saper, C.B., Drucker,
D.J., and Elmquist, J.K. (2002). Glucagon-like peptide-1 receptorStratford, T.R., and Kelley, A.E. (1999). Evidence of a functional
relationship between the nucleus accumbens shell and lateral hypo- stimulation increases blood pressure and heart rate and activates
autonomic regulatory neurons. J. Clin. Invest. 110, 43–52.thalamus subserving the control of feeding behavior. J. Neurosci.
19, 11040–11048. Yaswen, L., Diehl, N., Brennan, M.B., and Hochgeschwender, U.
(1999). Obesity in the mouse model of pro-opiomelanocortin defi-Stratford, T.R., Holahan, M.R., and Kelley, A.E. (1997). Injections of
Review
211
ciency responds to peripheral melanocortin. Nat. Med. 5, 1066–
1070.
Yeo, G.S., Farooqi, I.S., Aminian, S., Halsall, D.J., Stanhope, R.G.,
and O’Rahilly, S. (1998). A frameshift mutation in MC4R associated
with dominantly inherited human obesity. Nat. Genet. 20, 111–112.
Zald, D.H., Lee, J.T., Fluegel, K.W., and Pardo, J.V. (1998). Aversive
gustatory stimulation activates limbic circuits in humans. Brain 121,
1143–1154.
Zald, D.H., Hagen, M.C., and Pardo, J.V. (2002). Neural correlates
of tasting concentrated quinine and sugar solutions. J. Neurophys-
iol. 87, 1068–1075.
Zhang, M., and Kelley, A.E. (2000). Enhanced intake of high-fat food
following striatal mu-opioid stimulation: microinjection mapping and
fos expression. Neuroscience 99, 267–277.
Zhang, M., and Kelley, A.E. (2002). Intake of saccharin, salt, and
ethanol solutions is increased by infusion of a mu opioid agonist into
the nucleus accumbens. Psychopharmacology (Berl.) 159, 415–423.
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and
Friedman, J.M. (1994). Positional cloning of the mouse obese gene
and its human homologue. Nature 372, 425–432.
